
377: Melodrama at the FDA and the Pfizer-Novo bidding war
The Readout Loud
00:00
Why did Tidmarsh meet reporters about priority review concerns?
Lizzy recounts Tidmarsh's outreach, his legal concerns about a new priority voucher review program, and tensions with CBER.
Play episode from 12:22
Transcript


